AR086862A1 - Combinacion sinergica para el tratamiento de diabetes mellitus tipo 2 - Google Patents

Combinacion sinergica para el tratamiento de diabetes mellitus tipo 2

Info

Publication number
AR086862A1
AR086862A1 ARP120102026A ARP120102026A AR086862A1 AR 086862 A1 AR086862 A1 AR 086862A1 AR P120102026 A ARP120102026 A AR P120102026A AR P120102026 A ARP120102026 A AR P120102026A AR 086862 A1 AR086862 A1 AR 086862A1
Authority
AR
Argentina
Prior art keywords
treatment
diabetes
combination
mellitus type
refers
Prior art date
Application number
ARP120102026A
Other languages
English (en)
Inventor
Farouk Radwan
Original Assignee
Pri S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pri S A filed Critical Pri S A
Publication of AR086862A1 publication Critical patent/AR086862A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La presente se refiere a una combinación sinérgica de cromo trivalente, biotina y ginseng americano eficaz para el tratamiento de diabetes mellitus tipo 2. También se refiere a composiciones dietéticas que incluyen dicha combinación que resultan apropiadas para el tratamiento de diabetes mellitus tipo 2 en pacientes obesos. También se refiere a la utilización de dicha combinación para la preparación de un medicamento para el tratamiento de dicha diabetes.
ARP120102026A 2011-06-08 2012-06-07 Combinacion sinergica para el tratamiento de diabetes mellitus tipo 2 AR086862A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201130956A ES2395529B1 (es) 2011-06-08 2011-06-08 Combinación sinérgica para el tratamiento de la diabetes mellitus tipo 2.

Publications (1)

Publication Number Publication Date
AR086862A1 true AR086862A1 (es) 2014-01-29

Family

ID=46513800

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP120102026A AR086862A1 (es) 2011-06-08 2012-06-07 Combinacion sinergica para el tratamiento de diabetes mellitus tipo 2

Country Status (9)

Country Link
US (1) US20140106006A1 (es)
EP (1) EP2717872B1 (es)
AR (1) AR086862A1 (es)
BR (1) BR112013031487B1 (es)
ES (2) ES2395529B1 (es)
MX (1) MX354283B (es)
PT (1) PT2717872T (es)
UY (1) UY34120A (es)
WO (1) WO2012168854A1 (es)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2489235A (en) 1947-07-24 1949-11-22 Hoffmann La Roche Synthesis of biotin
IL134163A0 (en) 1997-08-08 2001-04-30 Nutrition 21 Chromium/biotin treatment of type ii diabetes
IT1311495B1 (it) 1999-06-09 2002-03-13 Mendes S U R L Composizione comprendente sfingomielinasi alcalina, utilizzabile qualeprodotto dietetico, integratore alimentare o medicamento.
EP1305018A4 (en) * 2000-08-02 2006-08-30 Pharmanutrients METHODS AND COMPOUNDS FOR PROPHYLAXIS AND / OR TREATMENT OF DIABETES AND GLUCOSE DEREGULATION
US6365176B1 (en) 2000-08-08 2002-04-02 Functional Foods, Inc. Nutritional supplement for patients with type 2 diabetes mellitus for lipodystrophy
ATE339961T1 (de) * 2001-02-27 2006-10-15 Nutrition 21 Inc Chromium/biotin behandlung von dyslipidemia
CN1273152C (zh) 2001-05-11 2006-09-06 上海展望集团有限公司 一种治疗糖尿病的胶囊及其生产方法
EP1874285B1 (en) 2005-04-07 2009-10-07 Astrum Therapeutics Pty, Ltd. Complementary compositions to reduce blood glucose levels and treat diabetes
CN101437503A (zh) 2006-02-21 2009-05-20 阿斯特鲁姆医疗有限公司 用于降低血糖水平和治疗糖尿病的组合物
US20080102137A1 (en) * 2006-10-31 2008-05-01 Guffey Manning V R Composition and method for etiological treatment and prevention of diseases and/or complications associated with chronic glucose metabolism destabilization
CN101390902A (zh) * 2008-10-10 2009-03-25 北京冠五洲生物科学研究院 用于优生优育预防出生缺陷与改善记忆的药物组合物

Also Published As

Publication number Publication date
BR112013031487A2 (pt) 2016-12-13
ES2579829T3 (es) 2016-08-17
EP2717872A1 (en) 2014-04-16
EP2717872B1 (en) 2016-04-06
PT2717872T (pt) 2016-07-11
UY34120A (es) 2013-01-03
BR112013031487B1 (pt) 2020-03-03
MX354283B (es) 2018-02-21
ES2395529A1 (es) 2013-02-13
MX2013014276A (es) 2014-05-28
WO2012168854A1 (en) 2012-12-13
ES2395529B1 (es) 2014-04-11
US20140106006A1 (en) 2014-04-17

Similar Documents

Publication Publication Date Title
BR112013029256A8 (pt) combinação farmacêutica para uso no tratamento de pacientes com diabetes tipo 2
MX2013009948A (es) Composiciones de insulina y cromo para el tratamiento y prevencion de diabetes, hipoglucemia y alteraciones relacionadas.
DOP2011000285A (es) 2-acetamido-5-aril-1, 2, 4-triazolonas sustituidas y su uso
MX2021000715A (es) Composiciones y metodos para tratar trastornos metabolicos.
HN2011001280A (es) Compuestos de arilo con sustituyentes heterociclicos y su uso
MX366090B (es) Combinación farmacéutica para usarse en mejorar la tolerancia a la glucosa en pacientes que padecen diabetes de tipo 2.
GT201200038A (es) Composicion para tratar la fibrosis quistica
GB201101459D0 (en) Novel compounds and thier effects on fedding behaviour
BR112014005025A2 (pt) composição farmacêutica para uso no tratamento de uma doença neurodegenerativa
AU2018256619A1 (en) Compounds for the treatment of obesity and methods of use thereof
CO7160080A2 (es) Composiciones lipídicas de racecadotrillo
MX2016000294A (es) Composicion farmaceutica para liberacion sostenida de lanreotida.
AR086422A1 (es) Metodo para el tratamiento de tumores solidos avanzados, volasertib
WO2012135528A3 (en) Galectin-3c combination therapy for human cancer
BR112017016497A2 (pt) composições e métodos para metabolismo muscular melhorado
DOP2010000400A (es) 7-sulfanilmetil-,7-sulfinilmetil- y 7-sulfonilmetilindoles sustituidos y el uso de los mismos
EA201301308A1 (ru) Комбинация для лечения сахарного диабета
CL2017000884A1 (es) Composición farmacéutica para usarse en el tratamiento o la prevención de deficiencias de vitaminas y minerales en pacientes que han sido sometidos a cirugía de derivación gástrica
AR098832A1 (es) Uso de laquinimod para retrasar la progresión de la enfermedad de huntington
HUP0800498A2 (en) Use of dihydralazine for the preparation of medicaments for treatment of diseases related to ssao level
AR086862A1 (es) Combinacion sinergica para el tratamiento de diabetes mellitus tipo 2
AR085736A1 (es) Compuestos de complejos de fe(iii) para el tratamiento y profilaxis de sintomas de deficiencia de hierro y anemias por deficiencia de hierro
ES2446494B1 (es) Aplicación terapéutica de necrostatina-1 en esteatohepatitis
BR112015012220A2 (pt) composição simbiótica e uso da mesma
BR112014015193A2 (pt) composição enriquecida com glicoproteína como um aditivo para alimento e/ou ração e/ou como um agente terapêutico

Legal Events

Date Code Title Description
FA Abandonment or withdrawal